International Myositis Assessment & Clinical Studies Group (IMACS)
Global Approaches To Improved Treatments And Understanding Of Myositis
News & Events
- 1-Jun-12: Myositis Response Criteria to be Developed (http://www.niehs.nih.gov/research/resources/collab/imacs/news_main/news_item2012jun26/index.cfm) (http://www.niehs.nih.govhttp://edit:9992/Rhythmyx/assembler/render?sys_authtype=0&sys_variantid=567&sys_revision=2&sys_contentid=74251&sys_context=0)
The International Myositis Assessment and Clinical Studies Group (IMACS) is a coalition of health care providers and researchers with experience and interest in the myositis syndromes.
The goals of IMACS are to improve the lives of children and adults who suffer from myositis by discovering better therapies through understanding the causes of these diseases.
IMACS members work to achieve these goals by developing consensus and standards on the conduct and reporting of adult and juvenile myositis studies, performing collaborative therapeutic trials and by planning, facilitating and conducting international collaborative myositis research.
The administrative arm of IMACS is housed in offices of the National Institute of Environmental Health Sciences (NIEHS) in the Mark O. Hatfield Clinical Research Center at the National Institutes of Health, Bethesda, MD, USA. This facility is the world's largest clinical research complex, serving a dual role: providing humane and healing patient care as well as the environment clinical researchers need to advance clinical science.
The Clinical Center complex is part of the NIH's intramural science research program. NIH is part of the U.S. Department of Health and Human Services and the medical research agency of the U.S Government.
This is the public site for IMACS. If you are already a member, you may wish to visit the members site on the NIEHS Extranet
If you are not a member yet and would like to be one, please go to the IMACS Membership page